NCT06432673

The Attractive 2 Trial - Pharmacokinetics of ATR-258 Oral Capsule vs. Oral Solution Formulations in Healthy Volunteers

The Attractive 2 Trial - An Open-label, Randomised, 2-period Cross-over Trial to Assess the Pharmacokinetics of ATR-258 Oral Capsule vs. Oral Solution Formulations in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 21 (actual)
• Sponsor: Atrogi AB · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This is a single-centre, open-label, randomised, 2-period cross-over, Phase 1 comparative trial to assess the ATR-258 pharmacokinetic (PK) parameters of an oral capsule formulation in comparison with an oral solution formulation, both given as single doses to healthy volunteers. The order of treatment, i.e., the treatment sequence capsule - solution or solution - capsule, will be randomised.

Conditions

• Type2diabetes

Interventions

Type	Name	Description
DRUG	ATR-258 Oral solution	Oral solution
DRUG	ATR-258 Oral capsule	Oral capsule

Timeline

• Start date: 2024-04-24
• Primary completion: 2024-05-27
• Completion: 2024-05-27
• First posted: 2024-05-29
• Last updated: 2024-07-01

Locations

1 site across 1 country: Sweden